Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This is an open-label, multicenter, dose-escalation, safety, tolerability, pharmacokinetic
and pharmacodynamic study in patients with advanced solid tumors.